Roche Holding is a diagnostics and pharmaceutical company. It offers pharmaceutical products for a wide range of diseases. The Company provides various diagnostic solutions, such as blood gas analysis, blood screening, cancer screening/monitoring, cardiac markers, cardiovascular testing, cholesterol monitoring, coagulation monitoring, diabetes monitoring, electrolytes analysis, real-time PCR diagnostic systems; and quality control service, data management and workflow solutions.

Type
Public
HQ
Basel, CH
Founded
1896
Size (employees)
93,734 (est)
Website
roche.com
Roche was founded in 1896 and is headquartered in Basel, CH
Report incorrect company information

Key People/Management at Roche

Severin Schwan

Severin Schwan

Chief Executive Officer Roche Group
Daniel ODay

Daniel ODay

CEO Roche Pharmaceuticals
Roland Diggelmann

Roland Diggelmann

CEO Roche Diagnostics
Alan Hippe

Alan Hippe

Chief Financial and IT Officer

Roche Office Locations

Roche has offices in Basel and South San Francisco
Basel, CH (HQ)
124 Grenzacherstrasse
South San Francisco, US
1 DNA Way
Show all (2)
Report incorrect company information

Roche Financials and Metrics

Roche Financials

Roche's revenue was reported to be CHF48.15 b in FY, 2015 which is a 1.4% increase from the previous period.
CHF

Revenue (FY, 2015)

48.1 b

Revenue growth (FY, 2014 - FY, 2015), %

1.4%

Gross profit (FY, 2015)

32.7 b

Gross profit margin (FY, 2015), %

67.9%

Net income (FY, 2015)

9.1 b

Market capitalization (22-Mar-2017)

213.9 b

Closing share price (22-Mar-2017)

250.1
Roche's current market capitalization is CHF213.9 b.
CHFFY, 2013FY, 2014FY, 2015

Revenue

46.8 b47.5 b48.1 b

Revenue growth, %

1%1%

Cost of goods sold

11.9 b13.4 b15.5 b

Gross profit

34.8 b34.1 b32.7 b
CHFFY, 2013FY, 2014FY, 2015

Cash From Operating Activities

15.8 b15.9 b15.3 b
Show all financial metrics

Roche Operating Metrics

Y, 2014Y, 2015Y, 2016

Drugs Approved by FDA

2

Major Approvals (US, EU, JP)

5 12

US FDA Breakthrough Therapy Designations

3 4 5
Show all operating metrics

Roche Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Flatiron Health (576)February 15, 2018$1.90 b
Ignyta December 22, 2017$1.70 b
mySugr June 30, 2017
Report incorrect company information